Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Net Income (2016 - 2025)

Enanta Pharmaceuticals filings provide 14 years of Net Income readings, the most recent being -$11.9 million for Q4 2025.

  • On a quarterly basis, Net Income rose 46.44% to -$11.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$71.4 million, a 33.16% increase, with the full-year FY2025 number at -$81.8 million, up 30.69% from a year prior.
  • Net Income hit -$11.9 million in Q4 2025 for Enanta Pharmaceuticals, up from -$18.6 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$11.9 million in Q4 2025 to a low of -$81.9 million in Q3 2021.
  • Median Net Income over the past 5 years was -$29.6 million (2021), compared with a mean of -$30.5 million.
  • Biggest five-year swings in Net Income: plummeted 503.91% in 2021 and later surged 67.3% in 2022.
  • Enanta Pharmaceuticals' Net Income stood at -$30.1 million in 2021, then increased by 3.75% to -$29.0 million in 2022, then dropped by 15.25% to -$33.4 million in 2023, then skyrocketed by 33.28% to -$22.3 million in 2024, then skyrocketed by 46.44% to -$11.9 million in 2025.
  • The last three reported values for Net Income were -$11.9 million (Q4 2025), -$18.6 million (Q3 2025), and -$18.3 million (Q2 2025) per Business Quant data.